Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

Among dozens of new laws signed this week by Gov. Jared Polis are consumer-friendly rules making it easier to cancel services ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

The average rate of teens beginning treatment ... we need these additional tools.” 0:57 Zepbound vs. Wegovy: Which weight-loss medication comes out on top? For its analysis, Truveta reviewed ...

American teens are increasingly turning to the weight-loss drug Wegovy, as more families and their doctors gain confidence in ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

The data shows that the average rate of adolescents starting treatment with the Novo Nordisk (NYSE: NVO) drug increased by 50 ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...